MCUJF — MEDICURE INC
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1133519 ·
Manitoba, Canada
Last close
$0.80
Market Cap
$8.35M
52W High
$0.96
52W Low
$0.75
ADV30
207
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 8,543,000 | 2,697,000 | -4,224,000 | -4,221,000 | 24,949,000 | 3,835,000 | 12,040,000 |
| Sep 2025 | 8,159,000 | 2,773,000 | -1,310,000 | -1,396,000 | 26,723,000 | 4,118,000 | 9,415,000 |
| Jun 2025 | 6,669,000 | 3,435,000 | -699,000 | -786,000 | 28,412,000 | 4,739,000 | 10,105,000 |
| Mar 2025 | 5,484,000 | 2,843,000 | -655,000 | -694,000 | 29,778,000 | 7,216,000 | 9,683,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-560,000
Investing CF
$-2,042,000
Financing CF
$-415,000
CapEx
$-548,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.21
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-73,988,000
Inventory
$2,942,000
Receivables
$4,817,000
ST Investments
—
EBIT TTM
$-6,859,000
Pretax Income TTM
$-6,889,000
Interest Exp TTM
$2,000
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 28,855,000 | -6,888,000 | -7,097,000 | 24,949,000 | 12,040,000 | — | -560,000 |
| Dec 2024 | 21,907,000 | -2,737,000 | -1,039,000 | 29,679,000 | 8,901,000 | — | 1,377,000 |
| Dec 2023 | 21,694,000 | -854,000 | -922,000 | 28,059,000 | 8,163,000 | — | 2,079,000 |
| Dec 2022 | 23,065,000 | 1,193,000 | 1,365,000 | 29,898,000 | 8,893,000 | — | 1,828,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.65
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ACXP | Acurx Pharmaceuticals, Inc. | $8.34M | $1.94 | — |
| NCNA | NuCana plc | $8.32M | $2.00 | — |
| IMRN | Immuron Ltd | $8.25M | $1.01 | — |
| ENVB | Enveric Biosciences, Inc. | $8.21M | $2.23 | — |
| GNPX | Genprex, Inc. | $8.17M | $0.77 | — |
News headlines (Yahoo Finance, 1h cache)
Medicure Inc (MCUJF) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic Acquisitions ...
2026-05-25 21:00 · Yahoo
Medicure Announces AGM Results and Appointment of New Director
2026-05-21 21:00 · Yahoo
Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
2026-05-21 21:00 · Yahoo
Medicure Inc (MCUJF) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Rising Losses
2026-04-28 07:02 · Yahoo
Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference Call
2026-04-23 22:15 · Yahoo
Medicure Announces Resignation of President and Chief Operating Officer
2026-04-17 23:35 · Yahoo
Medicure: Q3 Earnings Snapshot
2025-11-19 22:21 · Yahoo
Medicure Reports Financial Results for Quarter Ended September 30, 2025
2025-11-19 22:00 · Yahoo
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
2025-11-13 22:30 · Yahoo
Medicure Second Quarter 2025 Earnings: CA$0.08 loss per share (vs CA$0.12 loss in 2Q 2024)
2025-08-22 10:41 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.